NFE2L2 and benign prostatic hyperplasia: Nuclear factor erythroid 2-related factor 2 (Nrf2) further modulates BPH progression by enhancing antioxidant responses, promoting apoptosis, and inhibiting macrophage-mediated inflammation (96).